Navigation Links
Synthetic DNA Makes Better Hydrogels for Drug Delivery

Using synthetic DNA formed into crosses, Y's and T's, Cornell researchers have created biocompatible, biodegradable//, inexpensive hydrogels that can be easily formed into any desired shape for biomedical applications.

Hydrogels are liquid or semisolid materials composed of long-chain molecules cross-linked to one another to create many small empty spaces that can absorb water or other liquids like a sponge. If the spaces are filled with a drug, the hydrogel can dispense the drug gradually as the structure biodegrades. Widespread research also is under way on using hydrogels as scaffolds for tissue engineering and tissue repair, where the spaces in the gel might be filled with stem cells, tissue-growth factors or a combination of both.

Hydrogels for these purposes are usually made from organic or inorganic polymers (molecules that form long chains), such as alginate from seaweed. Some have been made from proteins but none entirely from ordinary DNA. So far, all these processes have used organic solvents or acids or involve high temperatures, making conditions too harsh for a drug or living cells, so the materials to be encapsulated must be loaded in afterward.

The new process, developed in the laboratory of Dan Luo, Cornell assistant professor of biological and environmental engineering, uses no high temperatures or harsh chemicals, so the material to be encapsulated in the gel can be introduced before the gel is formed. Because the gel is made of only synthetic DNA, no immune response should be triggered, the researchers said, so the material encapsulated can include proteins and even live mammalian cells.

The research was published Sept. 24 in the online version of Nature Materials and will appear in a forthcoming print issue of the journal.

A DNA molecule is a long chain in a sequence that is unique to each chain. Conveniently, two chains with complementary sequences can lock onto one another like two hal
'"/>




Page: 1 2

Related medicine news :

1. New Study Will The Look Into The Effects Of Synthetic Steroids
2. Synthetic protein found to relieve arthritis symptoms in animal model
3. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
4. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
5. Super Chow, Laced With Semi-Synthetic Vitamin E, Inhibited Spread of Cancer
6. Synthetic Chemicals May Trigger Breast Cancer
7. Synthetic Cannabinoid Could Improve Fertility in Smokers
8. Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness
9. What Makes Teens take Drugs
10. Music Makes you Smarter
11. New Healthy Weight Program Makes Healthy Eating More Interesting
Post Your Comments:
Breaking Medicine Technology:Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 6038 1Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 6038 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 1Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 3Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 1Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 2Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 3Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 4Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 5Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 6Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 7Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 8Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 9Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 10Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 11Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 12Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 13Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 14Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 15Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 16Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 17Allied World Reports Record Operating Results in Third Quarter 2009 3B 27 4 25 Increase in Total Book Value Year to Date 3B 11 25 Dividend Increase An 60798 18